-
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024
05 Jun 2024 12:00 GMT
… TNX-102 SL (Sublingual Cyclobenzaprine HCl) Significantly Improves … rejection and for the treatment of autoimmune diseases. … .S. Food and Drug Administration (FDA) as the tradename … Contact Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma.com …
-
Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
03 Jun 2024 12:00 GMT
… 3 RESILIENT trial of Tonmya (TNX-102 SL, cyclobenzaprine HCl … show benefits of traditional antidepressants in mild depression and … with FDA for the second quarter of 2024. Tonix Pharmaceuticals … rejection and for the treatment of autoimmune diseases. Tonix …
-
Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting
30 May 2024 12:00 GMT
… Pharmaceuticals. “While Tonix is preparing for submission of a New Drug … SL* (Sublingual Cyclobenzaprine HCl) – The OASIS Trial: Sustaining Civilian … and for the treatment of autoimmune diseases. … infectious disease. Tonix Medicines, our commercial subsidiary, …
-
Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
22 May 2024 12:00 GMT
… Translational Medicine
Title:
Effect of Bedtime Sublingual Cyclobenzaprine (TNX … and for the treatment of autoimmune diseases. … S. Food and Drug Administration (FDA) as the tradename … Contact Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma. …
-
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia
21 May 2024 12:00 GMT
… two Phase 3 trials
Primary physician research … with drugs currently approved by FDA for the treatment … medication. The tablet is a patented sublingual formulation of cyclobenzaprine … Contact Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma. …
-
Coweta deputy completes Drug Recognition Expert course
17 May 2024 20:04 GMT
… safely and recognizes drug-impaired drivers. Subjects include drug evaluation techniques, … effects of drugs, psychology and … .
Prescription medications such as Xanax, Klonopin, Prozac and Flexeril are some …
-
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
13 May 2024 20:30 GMT
… PK parameters of cyclobenzaprine are comparable in … treatment of PWS was granted Orphan Drug designation by the FDA … fully integrated pharmaceutical company. Tonix Pharmaceuticals has implemented … infectious disease. Tonix Medicines, our commercial subsidiary, …
-
What A Doctor Wants You To Know About Pelvic Floor Treatment
13 May 2024 13:34 GMT
… with your doctor.
Oral Medications
Gabapentin (Neurontin … treatment of nerve-related pain. Certain types of antidepressants … cyclobenzaprine can also temporarily relieve pelvic muscle spasm. All these medications … side effects than pills. Vaginal suppositories …
-
See The 50 Most Prescribed Drugs In The US Today
08 May 2024 16:06 GMT
… drugs, providing a snapshot of the most prevalent health concerns and treatment … a bit low!
45. Cyclobenzaprine
Source: fizkes / … Pravastatin is a statin medication utilized to lower … is a widely used antidepressant medication. It increases serotonin …
-
Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia
13 Feb 2024 13:00 GMT
… trials
New Drug Application (NDA) submission to the FDA … and Drug Administration (FDA) for the approval of Tonmya™ (cyclobenzaprine HCl … in a new treatment for the millions … the most innovative pharmaceutical, biotechnology and medical device companies as …